Results 101 to 110 of about 9,257 (204)

Plasma visfatin/nicotinamide phosphoribosyltransferase (visfatin/NAMPT) concentration is not related to kidney function in elderly subjects

open access: yesClinical Chemistry and Laboratory Medicine (CCLM), 2015
AbstractStudies assessing plasma visfatin/nicotinamide phosphoribosyltransferase (NAMPT) concentrations in chronic kidney disease with the ELISA method are restricted mainly to subjects with end-stage kidney disease. Therefore, little is known about to what extent glomerular filtration rate (GFR) affects the plasma levels of visfatin/NAMPT.
Piotr, Kocelak   +8 more
openaire   +3 more sources

Serum visfatin levels in Behçet's disease

open access: yesTURKDERM, 2015
Background and Design: The genetic predisposition, infectious agents, various antibodies and oxidative stress has been suggested to be among the possible causes of the etiopathogenesis of Behcet-s disease (BD). Recently, a new protein called visfatin, synthesized by adipose tissue has been identified.
EMİROĞLU, Nazan, CENGİZ, Fatma Pelin
openaire   +2 more sources

Visfatin/PBEF/Nampt: a new cardiovascular target? [PDF]

open access: yes, 2010
In the last years, a growing interest has emerged towards understanding the role of adipocytokines in the development of cardiometabolic complications. Five years ago, visfatin/PBEF/Nampt was identified as a novel adipocytokine.
Carlos F Sánchez-Ferrer   +7 more
core   +1 more source

Comparative evaluation of serum apelin, visfatin, and lipid levels in overweight hypertensive patients on enalapril versus telmisartan therapy [PDF]

open access: yesRomanian Journal of Medical Practice
Objectives. Visfatin and apelin are two adipokines that recently gained a special interest in hypertension research as they may have a role in the pathogenesis of hypertension and are closely related to the renin-angiotensin system.
Mina Khalid MOHAMMED   +3 more
doaj   +1 more source

Serum Visfatin Level in Gestational Diabetes Mellitus

open access: yes, 2019
ackground: Visfatin is a newly discovered adipocytokine. There is conflicting data regarding visfatin in gestational diabetes mellitus (GDM). Aim: The purpose of the present study was to investigate the possible alterations of serum levels of visfatin in
Nihad S. Shoeib , Maram M. M. Aboromia , Nesma A. Ibrahim, Eman A. Negm
core   +2 more sources

Visfatin increases miR-21 to promote migration in HCC

open access: yes, 2018
Hepatocellular carcinoma (HCC) is a common human malignancy. In this study, we aimed to investigate the serum levels of visfatin and miR-21 in HCC patients, to analysis the relationship between the pathological features and the plasma level of visfatin ...
Tianyu Liu   +4 more
core   +1 more source

Visfatin [PDF]

open access: yes, 2017
A. M. Gressner, O. A. Gressner
openaire   +1 more source

Visfatin Enhances RANKL-Induced Osteoclastogenesis In Vitro: Synergistic Interactions and Its Role as a Mediator in Osteoclast Differentiation and Activation

open access: yesBiomolecules
Visfatin, an adipokine secreted by various cell types, plays multifaceted pathophysiological roles in inflammatory conditions, including obesity, which is closely associated with osteoclastogenesis, a key process underlying bone loss and increased ...
Chang Youp Ok   +4 more
doaj   +1 more source

Visfatin and its Role in Breast Cancer [PDF]

open access: yes, 2017
Breast cancer, the most common cancer in women, is a leading cause of cancer death among women worldwide. Obesity is associated with increased risk of breast cancer.
Robab Sheikhpour
core  

Plasma visfatin levels and insulin sensitivity or resistance relationship in type 2 diabetes

open access: yesJournal of Contemporary Medical Sciences, 2017
Objective Many studies reported inconsistent results about the connection of visfatin with diabetes and insulin resistance (IR), and also the role of visfatin in the pathogenesis of diabetes are still under debate.
Shatha Abdul Wadood AL- Shammaree
doaj  

Home - About - Disclaimer - Privacy